Drugs / DPT-IPV-Hib
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03188692 | Jun → Nov 2017 | — | Tanabe Pharma Corporation | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DPT-IPV-Hib | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03188692 ↗ |
| Modality | Vaccine | “DPT-IPV-Hib (Combined Vaccine)” NCT03188692 ↗ |
| Route | Intramuscular | “0.5mL, intramuscular injection” NCT03188692 ↗ |